Vanderbilt Researchers Receive Heart Association Awards
Two Nashville-based investigators earned recognition at the 2026 American Heart Association Hypertension Scientific Sessions.
Updated on Oct. 22, 2026 in Heart Disease
In early October 2026, Vanderbilt Health researchers Mohammad Saleem and Annet Kirabo were honored with prestigious American Heart Association awards in Arlington, Virginia. The researchers were recognized for their respective contributions to the field of clinical hypertension and blood pressure science.
Why it matters
These awards highlight ongoing efforts to decode the complex immune cell mechanisms that drive salt-sensitive hypertension, a critical area of study for improving cardiovascular health outcomes. The recognitions reinforce the institutional commitment to advancing pharmacological research at Vanderbilt Health.
Mohammad Saleem completed two postdoctoral research fellowships at Vanderbilt Health before becoming a faculty member in 2017. His research focuses on the mechanisms underlying salt-sensitivity of blood pressure.
The players
Mohammad Saleem
He is a Research Instructor in Medicine at Vanderbilt Health who holds a PhD in pharmacology and pharmaceutical sciences from the University of Houston.
Annet Kirabo
She serves as a Professor of Medicine in the Division of Genetic Medicine and Clinical Pharmacology at Vanderbilt.
The details
The American Heart Association Council on Hypertension, alongside sponsors Data Sciences International and Sky Labs Inc, presented the awards to acknowledge excellence in clinical pharmacology. Saleem was honored with the 2026 Stephanie Watts Career Development Award, while Kirabo received the Established Investigator Award for Clinical Hypertension.
Timeline
Saleem joined the Vanderbilt faculty in 2017.
The awards were presented in early October 2026 at the Hypertension Scientific Sessions.
The Big Picture
This story is part of the broader dissemination of cardiovascular findings at the American Heart Association's Hypertension Scientific Sessions. It follows the annual pattern of the conference to highlight and award emerging cardiovascular research.
These research findings represent critical steps toward identifying new therapeutic targets for managing salt-sensitive blood pressure in patients. Ongoing studies like these may eventually lead to more personalized clinical treatment plans for hypertensive individuals.
The takeaway
Recognitions like these underscore the importance of academic investment in understanding the root causes of hypertension. For patients managing blood pressure, these advances signal a growing depth of knowledge regarding how immune function influences cardiovascular health.
Further reading
Learn more about the latest research and initiatives at the Heart Disease section.
Source note: This article includes information reported by The Tennessee Tribune.
